Intrathecal Pump Drug Delivery
Venduto da moluna, Greven, Germania
Venditore AbeBooks dal 9 luglio 2020
Nuovi - Rilegato
Condizione: Nuovo
Spedito da Germania a U.S.A.
Quantità: Più di 20 disponibili
Aggiungere al carrelloVenduto da moluna, Greven, Germania
Venditore AbeBooks dal 9 luglio 2020
Condizione: Nuovo
Quantità: Più di 20 disponibili
Aggiungere al carrelloDieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. This book is a comprehensive guide to Targeted Drug Delivery (TDD), also known as Intrathecal Drug Delivery (IDD), and offers an overview to this unique form of treatment. The medication is delivered by intrathecal pumps and is less common than some other t.
Codice articolo 492756330
Douglas P. Beall, MD, attended medical school at Georgetown University School of Medicine in Washington, DC, and completed his residency at The Johns Hopkins Hospital in Baltimore, Maryland. Following residency, he was Chief of Interventional Services at Sheppard Air Force Base in Wichita Falls, Texas. He then completed a fellowship in Musculoskeletal Radiology at Mayo Clinic in Rochester, Minnesota, where he was trained in interventional spine techniques before returning to the US Air Force as Division Chief of Musculoskeletal Radiology. Following his service as a Major in the US Air Force Dr. Beall was chief of Musculoskeletal Radiology and Fellowship Director at the Univiersity of Oklahoma prior to entering private practice as the Chief of Services.
In addition to his expertise in musculoskeletal imaging and interventional spine care, Dr. Beall is actively involved in teaching and research. He is board-certified in Diagnostic Radiology, has an added fellowship in Musculoskeletal Radiology, is a Diplomate of the American Academy of Pain Management and is a Fellow of the Society of Interventional Radiology and Interventional Pain Practice and board certified by the World Institute of Pain. He is currently in private practice focused on interventional pain management and orthopedic imaging.
Dr. Beall has published more than 250 articles in peer-reviewed journals, authored 6 textbooks and 75 textbook chapters, given more than 1000 invited lectures and scientific presentations and has participated in 55 clinical research trials. He is currently the Chief of Services for Comprehensive Specialty Care in Oklahoma City as well as the Division Head of Interventional Spine Care and Director of Pain Management Fellowship Programs at the Center for Comprehensive Specialty Care.Peter L Munk, MDCM, FRCPC, FSIR, FFRRCSI (Hon) is Professor of Radiology, Orthopedics and Palliative Care at the University of British Columbia and former Section Head Musculoskeletal Imaging at the Vancouver General Hospital in Vancouver, Canada. A medical graduate of McGill University in Montreal, Canada. Completed a Fellowship in musculoskeletal radiology at the University of California San Francisco.
Previous Editor in Chief of the Canadian Association of Radiologists Journal (2009-2019) and currently Associate Editor of the British Journal of Radiology, Advisor to the Editor Medical Journal of Australia. International Liaison for the Asian Pacific Association of Medical Journal Editors. Author of 460 published papers, 180 abstracts, 120 scientific exhibits, 5 books and 25 book chapters. Member of the International Skeletal Society, Fellow of the Society of Interventional Radiology and Honorary Fellow of the Faculty of Radiology of the Royal College of Surgeons in Ireland.Principle research interest includes musculoskeletal tumor imaging and Interventional imaging guided musculoskeletal procedures - particularly with regards to pain control in metastatic bone disease.
Michael J. DePalma, MD is President and Medical Director of Virginia iSpine Physicians, PC where he practices Interventional Spine and Musculoskeletal Care. Dr. DePalma completed his residency in Physical Medicine and Rehabilitation at The Ohio State University Medical Center in 2003 followed by his fellowship training in Interventional Spine Care at the Pennsylvania Spine Center of the Hospital of the University of Pennsylvania in 2004.
Dr. DePalma has authored or co-authored over eighty-five articles and abstracts in peer reviewed journals and twenty-one textbook chapters. He has also edited a forty-nine chapter textbook, iSpine: Evidence Based Interventional Spine Care, and co-edited a second textbook, Regenerative Medicine: The Intersection of Research and Experience. He serves or has served on multiple professional committees and boards for the North American Spine Society, The Spine Intervention Society, and the American Academy of Physical Medicine and Rehabilitation. Dr. DePalma is a reviewer for leading peer reviewed journals within his specialty as well as online patient education website. He serves as Director of Virginia iSpine Physician’s Interventional Spine Care Fellowship program and is also Chairman and Director of Research with Virginia Spine Research Institute. Dr. DePalma has been named by his peer physicians as a “Top Doc” in Richmond Magazine in 2008, 2011, and 2012, in Best Doctors in America 2015-2016, and in Virginia magazine in 2017. This esteemed recognition places Dr. DePalma within the top 10% of recognized physicians in this area. He is also the recipient of the 2018 Our Health Best Bedside Manner Award as well as the 2019 Medarva Patient Choice Award.Dr. DePalma is an active spine and musculoskeletal researcher with over 18 years of clinical research experience. As a Principal Investigator he has successfully conducted various phases of FDA regulated clinical trialsfor conditions such as degenerative disc disease (DDD), spinal stenosis, disc herniation, facet joint arthrosis, hip joint arthritis sacroiliac joint dysfunction, osteoporotic fractures and, more recently, knee osteoarthritis. His research has corroborated prevalence data on chronic low back pain and has also clarified predictor variables for the source of chronic low back pain and the etiology of chronic low back pain induced by motor vehicle collision. He was the lead investigator at VCU in the largest prospective study of an innovative non-surgical technique to stabilize painful pelvic fractures in osteoporotic patients.As an international speaker as an expert in his field, Dr. DePalma’s research has been recognized twice by the Spine Intervention Society as the “Best Clinical Paper” and “Best Basic Science Paper”.
Dr DePalma’s Clinical Research Team includes two Sub-Investigators including his fellows, a Certified Clinical Research Coordinator, a Clinical ResearchAssistant, and several Clinical Research Medical Assistants. Together, the research team at Virginia iSpine Physicians, PC has over 45 Years of combined clinical research experience.
Timothy T Davis, MD attended the University of Missouri-Kansas City School of Medicine 6 year Program, graduating with a combined BA/MD at 24 years of age. After earning his medical degree, Dr. Davis completed his surgical internship at Ochsner Medical Foundation in New Orleans, Louisiana then his residency in Physical Medicine and Rehabilitation at the West Los Angeles Veterans Administration and UCLA Medical Center. He then completed a post graduate Spine Fellowship at The Spine Institute in Santa Monica, CA.Dr. Davis has published extensively in peer reviewed journals, has written numerous book chapters, and has presented nationally and internationally on spine and joint disorders and treatments. He has been the principal investigator on more than 20 clinical trials,many focusing on biologics for spine and joint disorders.Dr Davis has been in Private Practice focused on Interventional Pain Management for his entire medical career and is the founder of Source Healthcare, Source Surgery Center, Source Practice Solutions IP Holdings, and Alpha Diagnostics.
Dr Davis is on medical staff at Saint Johns Health Center and Cedars Sinai Medical Center. He is a member of the North American Spine Society, American Academy of Physical Medicine and Rehabilitation, American Academy of Pain Medicine, North American Neuromodulation Society and American Society of Pain and Neuroscience.
Kasra Amirdelfan is one of the founding partners at IPM Medical Group, Inc., in Walnut Creek, California. He received his medical degree from Texas A&M University, College of Medicine. He completed his residency at John Peter Smith Hospital in Fort Worth, Texas, an affiliated facility with Southwestern School of Medicine. Dr.Amirdelfan completed his fellowship in Interventional Pain Management at Pacific Pain Treatment Centers with Dr. Elliot Krames, in collaboration with California Pacific Medical Centers in San Francisco. He has served as the Department Chair of Pain Medicine at John Muir Medical Center and Doctors Hospitals in his area. He performs extensive research and lectures various cutting edge methods in pain management at the national and international levels. He is regarded as one of the foremost global key opinion leaders in the field of Interventional Pain Management and Neuromodulation. He also continues to be actively involved in conducting research for the development of new technologies to help improve pain management worldwide. He has authored over 40 scientific peer-reviewed publications in his specialty. He in the Vice President of Clinical Affairs and an executive board member of the American Society of Pain & Neuroscience (ASPN). He is also the Vice President of PacificSpine & Pain Society (PSPS). Dr. Amirdelfan has a special interest in Spinal diseases, spinal cord stimulation and stem cell technologies.
Corey W. Hunter, M.D. is an interventional pain management physician practicing in New York City, holding board certifications in Physical Medicine & Rehabilitation and Pain Medicine.
Dr. Hunter earned his medical degree from Drexel University College of Medicine. Thereafter, he completed a residency in PM&R at New York University followed by a Pain Medicine fellowship at the Weill Cornell Medical Center. Dr. Hunter went on to found the Ainsworth Institute of Pain Management in New York City where he serves as the Executive Director. In addition, he holds an appointment as Assistant Clinical Professor in PM&R at the Icahn School of Medicine at Mount Sinai Medical Center.
Prior to attending medical school, Dr. Hunter worked as a research assistant at the Miami Project to Cure Paralysis investigatingembryonic stem cells to treat paralysis, Parkinson’s disease and chronic pain. He continued his research in medical school studying stromal stem cells (now known as mesenchymal) to treat paralysis – his work was amongst the earliest research on this particular cell line, which is now the mainstay of regenerative medicine.
Dr. Hunter continues to be active in research, serving as the principle investigator on a number of clinical trials on emerging neuromodulation technologies and regenerative medicine. He has a keen interest in teaching and is well-published with his work appearing in a number peer-reviewed journals and textbooks on a wide variety of topics that includes DRG Stimulation, pelvic pain, regenerative medicine, CRPS, amputee pain, advanced spinal cord stimulation techniques, and targeted drug delivery.
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Visita la pagina della libreria
Avviso di revoca/
Condizioni Generali di Contratto e informazioni per i clienti/
Informativa sulla privacy
Diritto di recesso per consumatori
(Il consumatore è qualsiasi persona fisica che conclude un negozio giuridico per scopi che non possono essere attribuiti alla sua attività professionale nè commerciale nè autonoma.)
Informativa sul diritto di recesso
Diritto di recesso
Il presente contratto può essere rescisso entro 1 mese senza obbligo di specificarne i motivi.
Il termine di revoca è di 1...
Se sei un consumatore puoi recedere dal contratto in conformità con quanto segue. Per Consumatore si intende qualsiasi persona fisica che agisce per scopi estranei alla propria attività commerciale, imprenditoriale, artigianale o professionale.
Informazioni sul diritto di recesso
Diritto legale di recesso
Hai il diritto di recedere dal presente contratto entro 14 giorni senza fornire alcuna motivazione.
Il periodo di recesso scade dopo 14 giorni dal giorno in cui tu o una terza parte, diversa dal vettore e da te indicata, acquisisce il possesso fisico dell'ultimo bene o dell'ultimo lotto o pezzo.
Per esercitare il diritto di recesso, compila e invia elettronicamente una dichiarazione esplicita sul nostro sito Web, alla voce “I miei acquisti” nella sezione “Mio account”. Ti comunicheremo senza indugio una conferma di ricezione di tale recesso su un supporto durevole (ad es. via e-mail).
Per rispettare il termine di recesso, è sufficiente inviare la comunicazione relativa all'esercizio del diritto di recesso prima della scadenza del periodo di recesso stesso.
Effetti del recesso
In caso di recesso dal presente contratto, ti rimborseremo tutti i pagamenti ricevuti, compresi i costi di spedizione (ad eccezione dei costi supplementari derivanti dalla tua eventuale scelta di un tipo di spedizione diverso dal tipo meno costoso di consegna standard da noi offerto).
Potremo effettuare una detrazione dal rimborso per la perdita di valore dei beni forniti, qualora tale perdita sia il risultato di una manipolazione non necessaria da parte tua.
Eseguiremo il rimborso senza indebito ritardo e non oltre 14 giorni dal giorno in cui saremo informati della tua decisione di recedere dal presente contratto.
Il rimborso sarà effettuato utilizzando lo stesso mezzo di pagamento da te usato per la transazione iniziale, salvo che tu non abbia espressamente concordato altrimenti; in ogni caso, non dovrai sostenere alcun costo quale conseguenza di tale rimborso.
Possiamo trattenere il rimborso finché non avremo ricevuto i beni oppure finché non avrai fornito la prova di averli rispediti, a seconda di quale condizione si verifichi per prima.
Dovrai rispedire i beni o consegnarli a moluna, Greven, Germany, senza indebito ritardo e, in ogni caso, entro 14 giorni dal giorno in cui ci hai comunicato la tua volontà di recedere dal presente contratto. Il termine è rispettato se rispedisci i beni prima della scadenza del periodo di 14 giorni. I costi diretti della restituzione dei beni saranno a tuo carico. Sei responsabile solo della diminuzione del valore dei beni risultante da una manipolazione diversa da quella necessaria per stabilire la natura, le caratteristiche e il funzionamento dei beni stessi.
Eccezioni al diritto di recesso
Il diritto di recesso non si applica a:
II. Kundeninformationen
Moluna GmbH
Engberdingdamm 27
48268 Greven
Deutschland
Telefon: 02571/5698933
E-Mail: abe@moluna.de
Wir sind nicht bereit und nicht verpflichtet, an Streitbeilegungsverfahren vor Verbraucherschlichtungsstellen teilzunehmen.
Die technischen Schritte zum Vertragsschluss, der Vertragsschluss selbst und die Korrekturmöglichkeiten erfolgen nach Maßgabe der Regelungen "Zustandekommen des Vertrages" unserer Allgemeinen Geschäftsbedingungen (Teil I.).
3.1. Vertragssprache ist deutsch .
3.2. Der vollständige Vertragstext wird von uns nicht gespeichert. Vor Absenden der Bestellung können die Vertragsdaten über die Druckfunktion des Browsers ausgedruckt oder elektronisch gesichert werden. Nach Zugang der Bestellung bei uns werden die Bestelldaten, die gesetzlich vorgeschriebenen Informationen bei Fernabsatzverträgen und die Allgemeinen Geschäftsbedingungen nochmals per E-Mail an Sie übersandt.
Die wesentlichen Merkmale der Ware und/oder Dienstleistung finden sich im jeweiligen Angebot.
5.1. Die in den jeweiligen Angeboten angeführten Preise sowie die Versandkosten stellen Gesamtpreise dar. Sie beinhalten alle Preisbestandteile einschließlich aller anfallenden Steuern.
5.2. Die anfallenden Versandkosten sind nicht im Kaufpreis enthalten. Sie sind über eine entsprechend bezeichnete Schaltfläche auf unserer Internetpräsenz oder im jeweiligen Angebot aufrufbar, werden im Laufe des Bestellvorganges gesondert ausgewiesen und sind von Ihnen zusätzlich zu tragen, soweit nicht die versandkostenfreie Lieferung zugesagt ist.
5.3. Die Ihnen zur Verfügung stehenden Zahlungsarten sind unter einer entsprechend bezeichneten Schaltfläche auf unserer Internetpräsenz oder im jeweiligen Angebot ausgewiesen.
5.4. Soweit bei den einzelnen Zahlungsarten nicht anders angegeben, sind die Zahlungsansprüche aus dem geschlossenen Vertrag sofort zur Zahlung fällig.
6.1. Die Lieferbedingungen, der Liefertermin sowie gegebenenfalls bestehende Lieferbeschränkungen finden sich unter einer entsprechend bezeichneten Schaltfläche auf unserer Internetpräsenz oder im jeweiligen Angebot.
Soweit im jeweiligen Angebot oder unter der entsprechend bezeichneten Schaltfläche keine andere Frist angegeben ist, erfolgt die Lieferung der Ware innerhalb von 3-5 Tagen nach Vertragsschluss (bei vereinbarter Vorauszahlung jedoch erst nach dem Zeitpunkt Ihrer Zahlungsanweisung).
6.2. Soweit Sie Verbraucher sind ist gesetzlich geregelt, dass die Gefahr des zufälligen Untergangs und der zufälligen Verschlechterung der verkauften Sache während der Versendung erst mit der Übergabe der Ware an Sie übergeht, unabhängig davon, ob die Versendung versichert oder unversichert erfolgt. Dies gilt nicht, wenn Sie eigenständig ein nicht vom Unternehmer benanntes Transportunternehmen oder eine sonst zur Ausführung der Versendung bestimmte Person beauftragt haben.
Sind Sie Unternehmer, erfolgt die Lieferung und Versendung auf Ihre Gefahr.
Die Mängelhaftung richtet sich nach der Regelung "Gewährleistung" in unseren Allgemeinen Geschäftsbedingungen (Teil I).
letzte Aktualisierung: 23.10.2019
| Quantità dell'ordine | Da 26 a 60 giorni lavorativi | Da 26 a 60 giorni lavorativi |
|---|---|---|
| Primo articolo | EUR 48.99 | EUR 48.99 |
I tempi di consegna sono stabiliti dai venditori e variano in base al corriere e al paese. Gli ordini che devono attraversare una dogana possono subire ritardi e spetta agli acquirenti pagare eventuali tariffe o dazi associati. I venditori possono contattarti in merito ad addebiti aggiuntivi dovuti a eventuali maggiorazioni dei costi di spedizione dei tuoi articoli.